Mark J. Sarnak
Impact in
- Nephrology top 0.01%
- Chronic Kidney Disease and Diabetes
- Dialysis and Renal Disease Management
- Parathyroid Disorders and Treatments
- Acute Kidney Injury Research
-
- Blood Pressure and Hypertension Studies
- Heart Failure Treatment and Management
- Cardiovascular Health and Disease Prevention
Papers in
- Nephrology 170
- Chronic Kidney Disease and Diabetes 97
- Dialysis and Renal Disease Management 71
- Parathyroid Disorders and Treatments 26
-
- Blood Pressure and Hypertension Studies 32
- Heart Failure Treatment and Management 13
- Co-authors
- Andrew S. Levey (75 shared papers)Michael G. Shlipak (106 shared papers)Hocine Tighiouart (60 shared papers)Ronit Katz (83 shared papers)Daniel E. Weiner (41 shared papers)Deeb N. Salem (26 shared papers)John L. Griffith (22 shared papers)David S. Siscovick (45 shared papers)
- Journals
- American Journal of Kidney Diseases (57 papers)Clinical Journal of the American Society of Nephrology (27 papers)Journal of the American Society of Nephrology (22 papers)Kidney International (21 papers)Nephrology Dialysis Transplantation (11 papers)
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
Mark J. Sarnak
286 papers receiving 27.4k citations
Mark J. Sarnak's Hit Papers
Peers
Comparison fields: 5 of 163
- Nephrology 13.2k
- Cardiology and Cardiovascular Medicine 5.2k
- Transplantation 439
- Hematology 1.4k
- Endocrinology, Diabetes and Metabolism 1.6k
Countries citing papers authored by Mark J. Sarnak
This map shows the geographic impact of Mark J. Sarnak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark J. Sarnak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark J. Sarnak more than expected).
Fields of papers citing papers by Mark J. Sarnak
This network shows the impact of papers produced by Mark J. Sarnak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark J. Sarnak. The network helps show where Mark J. Sarnak may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark J. Sarnak, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 289 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Kidney Disease as a Risk Factor for Development of Cardiovascular Disease Hit paper breakdown → | 2003 | 2947 |
| 2 | Cystatin C and the Risk of Death and Cardiovascular Events among Elderly Persons Hit paper breakdown → | 2005 | 982 |
| 3 | Chronic Kidney Disease as a Risk Factor for Cardiovascular Disease and All-Cause Mortality Hit paper breakdown → | 2004 | 959 |
| 4 | Kidney Disease as a Risk Factor for Development of Cardiovascular Disease Hit paper breakdown → | 2003 | 877 |
| 5 | Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community Hit paper breakdown → | 2002 | 711 |
| 6 | Cystatin C versus Creatinine in Determining Risk Based on Kidney Function Hit paper breakdown → | 2013 | 657 |
| 7 | Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients Hit paper breakdown → | 2000 | 633 |
| 8 | Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction Hit paper breakdown → | 2001 | 579 |
| 9 | Mortality caused by sepsis in patients with end-stage renal disease compared with the general population Hit paper breakdown → | 2000 | 519 |
| 10 | 2000 | 447 | |
| 11 | 2006 | 418 | |
| 12 | 2004 | 404 | |
| 13 | 2002 | 404 | |
| 14 | 2003 | 374 | |
| 15 | 2007 | 347 | |
| 16 | 2009 | 343 | |
| 17 | 2005 | 342 | |
| 18 | 2005 | 315 | |
| 19 | Cognitive Impairment in CKD: Pathophysiology, Management, and Prevention Hit paper breakdown → | 2019 | 274 |
| 20 | 2012 | 268 |
About Mark J. Sarnak
Mark J. Sarnak is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine, Surgery and Nutrition and Dietetics, having authored 289 papers that have together received 28.2k indexed citations. Recurring topics across this work include Chronic Kidney Disease and Diabetes (97 papers), Dialysis and Renal Disease Management (71 papers), Blood Pressure and Hypertension Studies (32 papers), Parathyroid Disorders and Treatments (26 papers), Heart Failure Treatment and Management (13 papers), Renal and Vascular Pathologies (12 papers), Vitamin D Research Studies (11 papers) and Folate and B Vitamins Research (9 papers). The work is most often cited by research in Nephrology (13.2k citations), Cardiology and Cardiovascular Medicine (5.2k citations), Transplantation (439 citations), Hematology (1.4k citations) and Endocrinology, Diabetes and Metabolism (1.6k citations). Mark J. Sarnak has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Andrew S. Levey, Michael G. Shlipak, Hocine Tighiouart, Ronit Katz, Daniel E. Weiner, Deeb N. Salem, John L. Griffith, David S. Siscovick, Josef Coresh and Linda F. Fried. Their work appears in journals such as American Journal of Kidney Diseases, Clinical Journal of the American Society of Nephrology, Journal of the American Society of Nephrology, Kidney International and Nephrology Dialysis Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.